MassMutual ratings affirmed by AM Best with stable outlook

MassMutual ratings affirmed by AM Best with stable outlook
Stable MassMutual ratings upheld

Massachusetts Mutual Life Insurance Company and several subsidiaries retain their existing AM Best credit ratings, underscoring continued strength in the insurer's capital position and operating profile. The stable outlook also extends to Manhattan National Life Insurance Company and to debt issued under MassMutual's funding programs.

Highlights

  • AM Best affirms MassMutual's A++ Financial Strength Rating and 'aa+' Long-Term Issuer Credit Ratings across Massachusetts Mutual and core subsidiaries, maintaining a stable outlook.
  • AM Best notes MassMutual's risk-adjusted capitalization remains very strong with further improvement expected in 2026, driven by reinsurance and a cash infusion from repurchasing Invesco-tied preferred shares.
  • AM Best cites MassMutual's effective management of elevated private credit exposures, robust liquidity, strong capital market access, and business repositioning towards whole life and institutional asset management products.

Rating actions and capital position

As reported by AM Best, MassMutual keeps its Financial Strength Rating of A++ and its Long-Term Issuer Credit Ratings of "aa+" across Massachusetts Mutual Life Insurance Company and its life and health subsidiaries, including C.M. Life Insurance Company, MML Bay State Life Insurance Company, MassMutual Ascend Life Insurance Company and Annuity Investors Life Insurance Company. At the same time, the agency affirms the Long-Term Issue Credit Ratings of "aa-" on MassMutual's surplus notes and "aa+" on notes issued under the funding agreement-backed securities programs of MassMutual Global Funding II.

AM Best says the ratings reflect MassMutual's balance sheet strength, which it assesses as strongest, along with strong operating performance, a very favorable business profile and very strong enterprise risk management. The agency says risk-adjusted capitalization remains at a very strong level under Best's Capital Adequacy Ratio, and it forecasts further strengthening in 2026, helped by reinsurance of the Universal Life business and a cash infusion tied to the repurchase of preferred shares from Invesco Ltd. [NYSE: IVZ].

MassMutual continues to carry elevated allocations to private placements, below investment-grade bonds and Schedule BA assets, but AM Best says those exposures are being managed effectively through Barings, supported by asset-liability management and stress testing. The agency also points to the insurer's access to capital markets, sufficient liquidity and leverage ratios that remain within its guidelines.

Business mix and implications for the insurance sector

AM Best says MassMutual continues to hold leading positions in life insurance, fixed and fixed-indexed annuities, institutional insurance products and asset management. The company has shifted its business mix in recent years toward whole life, fixed annuity, pension risk transfer and institutional asset management, while continuing to invest in technology across distribution platforms and in broader risk management and innovation efforts.

For Manhattan National Life Insurance Company, AM Best affirms a Financial Strength Rating of B++ and a Long-Term Issuer Credit Rating of "bbb+", both with a stable outlook. The agency says Manhattan Life's book is in run-off mode, with most liabilities reinsured through highly rated reinsurers, while its capitalization has improved as liabilities decline, even though earnings remain volatile and sensitive to relatively small changes in life claims.

The rating actions also cover MassMutual Global Funding II's program rating of "aa+" and multiple senior secured medium-term notes due between 2029 and 2033, as well as outstanding MassMutual surplus notes due between 2033 and 2077. AM Best also affirms an AMB-1+ short-term issue credit rating on MassMutual's commercial paper program.

As we noted earlier, AM Best rated Fairfax’s new senior notes with a stable outlook and unchanged issuer ratings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.